2009 Dec 17 - Lancet Viewpoint: A new law for allocation of donor organs in Israel

Prof Jacob Lavee MD a b , Tamar Ashkenazi MSc b, Prof Gabriel Gurman MD b, Prof David Steinberg MD c d. The Lancet, Early Online Publication, 17 December 2009
Israel's system for organ donation has been based, since its inception in 1968, on a model in which organs for transplantation are retrieved from brain-dead donors only after consent has been obtained from the appropriate first-degree relatives. This consent is needed even if the potential donor has expressed a wish for posthumous organ donation by signing a donor card, which is a government form that allows people to voluntarily indicate their wish to donate specified organs after their death. 1 ...

Read more ...

2009 Dec 12 - Risk of bleeding in patients with acute myocardial infarction treated with different combinations of aspirin, clopidogrel, and vitamin K antagonists in Denmark: a retrospective analysis of nationwide registry data

Dr Rikke Sørensen MD a , Morten L Hansen MD a, Steen Z Abildstrom MD b c, Anders Hvelplund MD c, Charlotte Andersson MB a, Casper Jørgensen MD a, Jan K Madsen MD a, Peter R Hansen MD a, Prof Lars Køber MD d, Prof Christian Torp-Pedersen MD a, Gunnar H Gislason MD a. The Lancet, Volume 374, Issue 9706, Pages 1967 - 1974, 12 December 2009

Background
Combinations of aspirin, clopidogrel, and vitamin K antagonists are widely used in patients after myocardial infarction. However, data for the safety of combinations are sparse. We examined the risk of hospital admission for bleeding associated with different antithrombotic regimens.

Read more ...

2009 Dec 10 - Lancet Comment: Molecular methods for pathogen detection in blood

Shin Lin a, Samuel Yang bThe Lancet, Early Online Publication, 10 December 2009
Detection of blood-borne infection is done with a multistep approach, including blood culture, single-colony growth, and biochemical analysis ( figure ). With automation of biochemical analysis, the complete process typically takes 2 days, 1 during which time clinicians receive incremental information about culture positivity with microscopic description, speciation, and antimicrobial susceptibility. Timely initiation of adequate antimicrobial treatment is crucial to reduce morbidity and mortality i ...

Read more ...

2009 Dec 10 - Accurate and rapid identification of bacterial species from positive blood cultures with a DNA-based microarray platform: an observational study

Päivi Tissari MD a, Prof Alimuddin Zumla FRCP b, Eveliina Tarkka MSc a, Sointu Mero MSc a, Laura Savolainen MSc a, Martti Vaara MD a, Anne Aittakorpi BEng c, Sanna Laakso c, Merja Lindfors BLS c, Heli Piiparinen PhD c, Minna Mäki PhD c, Caroline Carder FIBMS b, Jim Huggett PhD b, Dr Vanya Gant FRCP b. The Lancet, Early Online Publication, 10 December 2009doi:10.1016/S0140-6736(09)61569-5
The Prove-it Sepsis assay used in the study. Read more at its website here.
Background: New DNA-based microarray platforms enable rapid detection and species identification of many pathogens, including bacteria. We assessed the sensitivity, specificity, and turnaround time of a new molecular sepsis assay.

Read more ...

2009 Dec - Stroke treatment with alteplase given 3·0—4·5 h after onset of acute ischaemic stroke (ECASS III): additional outcomes and subgroup analysis of a randomised controlled trial

Erich Bluhmki PhD a, Ángel Chamorro MD b, Antoni Dávalos MD c, Thomas Machnig MD d, Christophe Sauce MS e, Nils Wahlgren MD f, Joanna Wardlaw MD g, Werner Hacke MD h. The Lancet Neurology, Volume 8, Issue 12, Pages 1095 - 1102, December 2009
Background: In the European Cooperative Acute Stroke Study III (ECASS III), alteplase administered 3·0—4·5 h after the onset of stroke symptoms resulted in a significant benefit in the primary endpoint (modified Rankin scale [mRS] score 0—1) versus placebo, with no difference in mortality between the treatment groups. Compared with the 0—3 h window, there was no excess risk of symptomatic intracranial haemorrhage. We assessed the usefulness of additional endpoints and did subgroup and sensitivity analyses to further investigate the benefit of alteplase.

Read more ...

2009 Nov 12 - Lancet Comment: Infection and death from influenza A H1N1 virus in Mexico

V Alberto Laguna-Torres a, Jorge Gomez Benavides b c. The Lancet, Early Online Publication, 12 November 2009
The scientific community is aware that pandemics other than the current influenza A H1N1 outbreak have existed throughout history. A characteristic of the H1N1 pandemic is how fast knowledge evolved, with medical groups confirming or declaring as controversial what had been stated weeks after the first outbreaks. This rapid evolution allowed other groups to establish better capabilities to face the pandemic.

Read more ...

2009 Nov 12 - Infection and death from influenza A H1N1 virus in Mexico: a retrospective analysis

Santiago Echevarría-Zuno MD a, Juan Manuel Mejía-Aranguré PhD b, Alvaro J Mar-Obeso MD b, Concepción Grajales-Muñiz MD b, Eduardo Robles-Pérez MSc b, Margot González-León MD b, Manuel Carlos Ortega-Alvarez MSc b, Cesar Gonzalez-Bonilla PhD b, Ramón Alberto Rascón-Pacheco MSc b, Dr Víctor Hugo Borja-Aburto PhD b Summary. The Lancet, Early Online Publication, 12 November 2009
Background
In April, 2009, the first cases of influenza A H1N1 were registered in Mexico and associated with an unexpected number of deaths. We report the timing and spread of H1N1 in cases, and explore protective and risk factors for infection, severe disease, and death.

Read more ...

2009 Nov 10 - Lancet Comment: InFACT - a global critical care research response to H1N1

The InFACT Global H1N1 Collaboration. The The Lancet, Early Online Publication, 10 November 2009
H1N1 pandemic presents acute care researchers with an extraordinary challenge and an unprecedented opportunity. By early October, 2009, there had been more than 340 000 reported cases of H1N1 infection in 191 countries, with more than 4100 deaths.1 WHO initially projected that up to 2 billion people could become infected with the virus over the next 2 years.2

Read more ...

2009 Nov 5 - Lancet Comment: Routine daily vs on-demand chest radiographs in intensive care

Mark D Siegel a, Ami N Rubinowitz b. The Lancet, Early Online Publication, 5 November 2009
Routine daily chest radiography is common in intubated and mechanically ventilated patients, in accord with professional society recommendations. 1 A key justification is the belief that routine chest radiographs allow prompt detection of problems that could be missed by clinical evaluation (eg, early pneumothoraces or malpositioned endotracheal tubes). 2

Read more ...

2009 Nov 5 - Comparison of routine and on-demand prescription of chest radiographs in mechanically ventilated adults: a multicentre, cluster-randomised, two-period crossover study

Dr Gilles Hejblum PhD a b d , Ludivine Chalumeau-Lemoine MD e, Vincent Ioos MD e, Pierre-Yves Boëlle PhD a b d, Laurence Salomon MD h, Prof Tabassome Simon MD c f, Jean-François Vibert MD a b g, Prof Bertrand Guidet MD a b e. The Lancet, Early Online Publication, 5 November 2009

Figure. Near-total right lung collapse due to sputum retention (Photo courtesy: Intensive Care Unit, PYNEH)
Background
Present guidelines recommend routine daily chest radiographs for mechanically ventilated patients in intensive care units. However, some units use an on-demand strategy, in which chest radiographs are done only if warranted by the patient's clinical status. By comparison between routine and on-demand strategies, we aimed to establish which strategy was more efficient and effective for optimum patient care.

Read more ...

2009 Nov 3 - Seminar: Pulmonary embolism in pregnancy

Dr Ghada Bourjeily MD a , Michael Paidas MD c, Hanan Khalil MD b, Prof Karen Rosene-Montella MD a, Marc Rodger MD d. The Lancet, Early Online Publication, 3 November 2009
Pulmonary embolism (PE) is the leading cause of maternal mortality in the developed world. Mortality from PE in pregnancy might be related to challenges in targeting the right population for prevention, ensuring that diagnosis is suspected and adequately investigated, and initiating timely and best possible treatment of this disease.

Read more ...

2009 Oct 31 - Seminar: Pathogenesis, treatment, and prevention of pneumococcal pneumonia

Prof Tom van der Poll MD a , Prof Steven M Opal MD b. The Lancet, Volume 374, Issue 9700, Pages 1543 - 1556, 31 October 2009
Pneumococcus remains the most common cause of community-acquired pneumonia worldwide. Streptococcus pneumoniae is well adapted to people, and is a frequent inhabitant of the upper airways in healthy hosts.

Read more ...

2009 Oct 3 - Case Report: Cyanide poisoning in Taiwan

Dr Dong-Zong Hung MD a , Yu-Tse Tsan MD b, Yi-Jung Yu b, Chia-Lung Hsu MT b. The Lancet, Volume 374, Issue 9696, Page 1212, 3 October 2009
In May, 2005, a 32-year-old woman lost consciousness soon after drinking a non-alcoholic beverage. She was transported to hospital within 5 min, found to be unresponsive, and intubated. Before intubation, blood gas measurements on room air (possible venous sample), were: pH 7·846, pCO2 24·2 mm Hg, pO2 28·7 mm Hg, HCO3− 41·8 mmol/L (base excess [BE] 26 mmol/L); O2 saturation was 79·4%.

Read more ...

2009 Sep 26 - Use of drains versus no drains after burr-hole evacuation of chronic subdural haematoma: a randomised controlled trial

Thomas Santarius MRCS a, Peter J Kirkpatrick FMedSci a, Dharmendra Ganesan FRCS[SN] a, Hui Ling Chia MMed a, Ibrahim Jalloh MRCS a, Peter Smielewski PhD a, Hugh K Richards PhD a, Hani Marcus MRCS a, Richard A Parker MSc b, Stephen J Price FRCS[SN] a, Ramez W Kirollos FRCS[SN] a, Prof John D Pickard FMedSci a, Peter J Hutchinson FRCS[SN] a The Lancet, Volume 374, Issue 9695, Pages 1067 - 1073, 26 September 2009
Background
Chronic subdural haematoma causes serious morbidity and mortality. It recurs after surgical evacuation in 5—30% of patients. Drains might reduce recurrence but are not used routinely. Our aim was to investigate the effect of drains on recurrence rates and clinical outcomes.

Read more ...

2009 Sep 26 - Case Report: Serious postoperative syncope

Dr Chih-Hung Kuo MB BS a , Dilan Kamalasena MB BS c, Nay Min Htun MRCP d, Suresh Singarayar FRACP b, Brian Bailey FRACP b.The Lancet, Volume 374, Issue 9695, Page 1118, 26 September 2009
In November, 2008, an arrest call was made for a 69-year-old woman after a syncopal episode in a rural hospital. The patient had had an elective right total hip replacement a day earlier.

Read more ...

2009 Oct - Susceptibility relationship between vancomycin and daptomycin in Staphylococcus aureus: facts and assumptions

Pamela A Moise, Donald North, Judith N Steenbergen, George Sakoula;
The Lancet Infectious Diseases, Volume 9, Issue 10, Pages 617 - 624, October 2009

The decrease in vancomycin treatment efficacy that is accompanying increases in vancomycin minimum inhibitory concentration (MIC) within the susceptible range (so-called MIC creep) has led to the suggestion that vancomycin is losing its potency in treating serious Staphylococcus aureus infections. Understanding the clinical importance of the microbiological effects of glycopeptides on bacterial lipopeptides and lipoglycopeptides will be crucial in treating serious meticillin-resistant S aureus infections.

Read more ...

2009 Oct - Influenza as a trigger for acute myocardial infarction or death from cardiovascular disease: a systematic review

Charlotte Warren-Gash, Liam Smeeth, Andrew C Hayward;
The Lancet Infectious Diseases, Volume 9, Issue 10, Pages 601 - 610, October 2009
Cardiac complications of influenza infection, such as myocarditis, are well recognised, but the role of influenza as a trigger of acute myocardial infarction is less clear. We did a systematic review of the evidence that influenza (including influenza-like illness and acute respiratory infection) triggers acute myocardial infarction or cardiovascular death. We examined the effectiveness of influenza vaccines at protecting against cardiac events and did a meta-analysis of data from randomised controlled trials.

Read more ...

2009 Sep 19 - Pharmacodynamic effect and clinical efficacy of clopidogrel and prasugrel with or without a proton-pump inhibitor: an analysis of two randomised trials

Dr Michelle L O'Donoghue MD a , Prof Eugene Braunwald MD a, Prof Elliott M Antman MD a, Sabina A Murphy MPH a, Prof Eric R Bates MD b, Prof Yoseph Rozenman MD c, Alan D Michelson MD d, Raymond W Hautvast MD e, Peter N Ver Lee MD f, Sandra L Close PhD g, Lei Shen PhD g, Jessica L Mega MD a, Marc S Sabatine MD a, Stephen D Wiviott MD a. The Lancet, Volume 374, Issue 9694, Pages 989 - 997, 19 September 2009
Background
Proton-pump inhibitors (PPIs) are often prescribed in combination with thienopyridines. Conflicting data exist as to whether PPIs diminish the efficacy of clopidogrel. We assessed the association between PPI use, measures of platelet function, and clinical outcomes for patients treated with clopidogrel or prasugrel.

Read more ...

2009 Oct - Review: Blood pressure as a prognostic factor after acute stroke

Valérie Tikhonoff MD a b c, Haifeng Zhang MD a d, Tom Richart MD a e, Jan A Staessen MD a e. The Lancet Neurology, Volume 8, Issue 10, Pages 938 - 948, October 2009
Stroke is the second most common cause of death worldwide and is the complication of hypertension that is most directly linked to blood pressure. Hypertension affects nearly 30% of the world's population; therefore, reducing blood pressure is key for the prevention of stroke.

Read more ...

2009 Oct - Review: Malignant middle cerebral artery infarction: clinical characteristics, treatment strategies, and future perspectives

Hagen B Huttner MD a, Stefan Schwab MD a SummaryThe Lancet Neurology, Volume 8, Issue 10, Pages 949 - 958, October 2009
Space-occupying, malignant middle cerebral artery (MCA) infarctions are still one of the most devastating forms of ischaemic stroke, with a mortality of up to 80% in untreated patients. An early diagnosis is essential and depends on CT and MRI to aid the prediction of a malignant course.

Read more ...